Spinal anesthesia may cut opioid needs after hysterectomy

NCT ID NCT06642649

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 16, 2026 · Updated 1 time

Summary

Researchers compare general anesthesia alone with two combined general and spinal anesthesia approaches in women having laparoscopic hysterectomy. The trial measures how much morphine patients use in the first 24 and 48 hours after surgery, along with pain scores, nausea, and other side effects. About 45 patients will take part. The goal is to see which method reduces opioid consumption and improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
general anesthesia alone or combined with spinal anesthesia using local anesthetic, morphine, with or without fentanyl
What this could lead to
If one approach works better, it could guide anesthesia choices that reduce opioid needs and related side effects after laparoscopic hysterectomy.
What could go wrong
The trial is small and early, so results may not apply broadly. Spinal anesthesia carries risks like low blood pressure, and individual responses vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * patients over 18 year of age, * ASA physical status I to III scheduled for laparoscopic hysterectomy (with or without adnexectomy) Exclusion Criteria: * patients with inability to consent, * patient refusal, * contraindication to spinal anesthesia (e.g., hemodynamic instability, infection at the surgery site, and neurologic defects such as transverse myelitis, coagulopathies or ongoing anticoagulant therapy), * known chronic pain syndrome, known * suspected non- compliance, * drug, or alcohol abuse , * major oncological surgeries, * allergy to drugs used in the protocol, * previous chronic use of analgesics * history of opioid abuse

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gynecology are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ente Ospedaliero Cantonale ORBV

    RECRUITING

    Bellinzona, Switzerland, 6500, Switzerland

  • Ente Ospedaliero Cantonale, Ospedale Regionale di Bellinzona e Valli

    NOT_YET_RECRUITING

    Bellinzona, Switzerland, 6500, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.